View Section: Financials
TB Statements
TB
TB Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2022-09-30
%
—
100
—
0
—
0
—
0
0.041
0
0.423
0
-0.423
0
0.903
0
0.71
0
1.19
0
—
0
1.19
0
0.048
25
2022-06-30
%
—
100
—
0
—
0
—
0
0.178
0
0.791
0
-0.791
0
0.27
0
1.395
0
0.874
0
—
0
0.874
0
0.035
25
2022-03-31
%
—
100
—
0
—
0
—
0
0.267
0
0.907
0
-0.907
0
0.02
0
2.969
0
2.082
0
—
0
2.082
0
0.083
25
2021-12-31
%
—
100
—
0
—
0
—
0
0.267
0
2.124
0
-2.124
0
0.774
0
0.011
0
-1.344
0
—
0
-1.344
0
-0.053
25.403
2021-09-30
%
—
100
—
0
—
0
—
0
—
0
1.104
0
-1.104
0
4.623
0
—
0
3.52
0
—
0
3.52
0
0.141
25
2021-06-30
%
—
100
—
0
—
0
—
0
—
0
0.374
0
-0.374
0
3.527
0
0.034
0
3.187
0
—
0
3.187
0
0.128
25
2021-03-31
%
—
100
—
0
—
0
—
0
—
0
0.041
0
-0.041
0
0.55
0
—
0
0.281
0
—
0
0.281
0
0.011
25.003
View Section: Balance Sheet